Progress with a recombinant whooping cough vaccine: a review.
作者信息
Burnette W N, Mar V L, Whiteley D W, Bartley T D
机构信息
Amgen Inc, Amgen Centre, Thousand Oaks, CA 91320.
出版信息
J R Soc Med. 1992 May;85(5):285-7. doi: 10.1177/014107689208500515.
Abstract
摘要
相似文献
1
Progress with a recombinant whooping cough vaccine: a review.
J R Soc Med. 1992 May;85(5):285-7. doi: 10.1177/014107689208500515.
2
The advent of recombinant pertussis vaccines.
Biotechnology (N Y). 1990 Nov;8(11):1002-5. doi: 10.1038/nbt1190-1002.
3
Towards third-generation whooping cough vaccines.
Trends Biotechnol. 1991 Jul;9(7):232-8. doi: 10.1016/0167-7799(91)90076-t.
4
Engineering bacterial toxin for the development of new vaccine against pertussis.
Tokai J Exp Clin Med. 1988;13 Suppl:217-22.
5
Detoxification of pertussis toxin by site-directed mutagenesis: a review of connaught strategy to develop a recombinant pertussis vaccine.
Mol Immunol. 1991 Mar;28(3):235-8. doi: 10.1016/0161-5890(91)90067-t.
6
7
[Cellular and acellular anti-pertussis vaccines].
Ann Pharm Fr. 2001 May;59(3):198-205.
8
Rational design of vaccines.
Nat Med. 1997 Apr;3(4):374-6. doi: 10.1038/nm0497-374.
9
Stable expression of pertussis toxin in Bordetella bronchiseptica under the control of a tightly regulated promoter.
Appl Environ Microbiol. 1997 Jan;63(1):122-7. doi: 10.1128/aem.63.1.122-127.1997.
10
Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
Bioeng Bugs. 2011 Nov-Dec;2(6):315-9. doi: 10.4161/bbug.2.6.18167. Epub 2011 Nov 1.
本文引用的文献
1
The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein.
Arch Biochem Biophys. 1983 Jul 1;224(1):290-8. doi: 10.1016/0003-9861(83)90212-6.
2
Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.
Infect Immun. 1983 Jun;40(3):1198-203. doi: 10.1128/iai.40.3.1198-1203.1983.
3
The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study.
Curr Probl Pediatr. 1984 Feb;14(2):1-78. doi: 10.1016/0045-9380(84)90016-1.
4
A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.
J Biol Chem. 1983 Jun 10;258(11):6756-61.
5
Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.
Biochemistry. 1982 Oct 26;21(22):5516-22. doi: 10.1021/bi00265a021.
6
Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
Infect Immun. 1984 Nov;46(2):422-8. doi: 10.1128/iai.46.2.422-428.1984.
7
The concept of pertussis as a toxin-mediated disease.
Pediatr Infect Dis. 1984 Sep-Oct;3(5):467-86. doi: 10.1097/00006454-198409000-00019.
8
Pertussis toxin gene: nucleotide sequence and genetic organization.
Science. 1986 Jun 6;232(4755):1258-64. doi: 10.1126/science.3704651.
9
Pertussis in Sweden after the cessation of general immunization in 1979.
Pediatr Infect Dis J. 1987 Apr;6(4):364-71. doi: 10.1097/00006454-198704000-00005.
10
The return of pertussis.
Pediatr Infect Dis J. 1987 Feb;6(2):141-4. doi: 10.1097/00006454-198702000-00001.
Zotero 插件